小崧股份(002723) - 2021 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2021 was ¥336,955,898.11, a decrease of 0.16% compared to the same period last year, while year-to-date revenue increased by 37.46% to ¥1,016,159,656.10[6] - Net profit attributable to shareholders for Q3 2021 was ¥919,563.34, down 89.02% year-on-year, and year-to-date net profit decreased by 63.74% to ¥7,161,115.80[6] - The basic earnings per share for Q3 2021 was ¥0.0029, a decline of 93.38% compared to the same period last year, with year-to-date earnings per share down 69.25% to ¥0.0318[6] - Total operating revenue for the third quarter reached CNY 1,016,159,656.10, an increase of 37.5% compared to CNY 739,245,189.44 in the same period last year[26] - Net profit for the quarter was CNY 6,924,609.86, a decrease of 65.0% from CNY 19,748,392.65 in the previous year[27] Assets and Liabilities - Total assets at the end of Q3 2021 reached ¥1,649,155,043.61, reflecting a 10.71% increase from the end of the previous year[6] - The company's total assets reached CNY 1,649,155,043.61, up from CNY 1,489,562,236.44, indicating a growth of 10.7%[24] - Total liabilities increased to CNY 1,003,146,917.40, compared to CNY 851,626,395.51, reflecting a rise of 17.8%[24] - The company reported a total current assets of 1,025,402,758.60 RMB as of September 30, 2021, an increase from 904,294,017.97 RMB at the end of 2020[22] Shareholder Information - The total number of common shareholders at the end of the reporting period is 8,712[15] - The largest shareholder, Shenzhen Huaxin Chuangli Technology Industrial Development Co., Ltd., holds 29.09% of shares, totaling 78,387,862 shares, which are pledged and frozen[15] - The top ten shareholders include several individuals with significant stakes, collectively holding approximately 25% of the company's shares[16] Cash Flow - Cash flow from operating activities for the period was CNY 845,753,422.29, compared to CNY 719,392,698.77 in the previous year, representing a growth of 17.6%[30] - Operating cash inflow totaled CNY 983,216,367.16, an increase from CNY 773,473,549.58 in the previous year, reflecting a growth of approximately 27%[31] - Operating cash outflow amounted to CNY 1,034,895,325.11, compared to CNY 714,587,655.09 last year, resulting in a net cash flow from operating activities of -CNY 51,678,957.95, down from CNY 58,885,894.49[31] - The net increase in cash and cash equivalents was -CNY 53,015,488.63, compared to -CNY 2,447,381.40 in the previous year[32] - The ending balance of cash and cash equivalents was CNY 57,119,571.77, down from CNY 70,380,213.81 last year[32] Expenses and Costs - Research and development expenses increased by 44.53% to ¥9,855,713.30, driven by expanded investment in health appliance categories[13] - Total operating costs amounted to CNY 1,006,397,649.15, up from CNY 733,958,296.59, reflecting a year-over-year increase of 37.0%[26] - The overall gross profit margin decreased due to rising raw material and labor costs, impacting the company's profitability[13] Government Support - The company received government subsidies totaling ¥3,111,925.20, primarily from local government tax rebates[9] - The comprehensive loss for Q3 2021 was ¥13,449,169.07, a decrease of 66.25% compared to the previous year, largely due to reduced government subsidies and increased operational costs[13] Investments - The company has a long-term equity investment of 75,044,536.14 RMB, up from 20,038,652.36 RMB at the end of 2020[22] - The company received a total of 4,095 million RMB from the equity transfer agreement, with 1,005 million RMB still outstanding[19] - The company plans to complete the payment of the remaining equity transfer amount by November 30, 2021[20] Regulatory and Reporting - The company is undergoing a non-public offering of shares, approved by the China Securities Regulatory Commission, with a validity period of 12 months[17] - The company did not undergo an audit for the third quarter report[33] - The report was released on October 29, 2021[34]